guanabenz has been researched along with Multiple Sclerosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Thompson, KK; Tsirka, SE | 1 |
| Chen, Y; Jones, J; Kunjamma, RB; Lin, W; Miller, SD; Podojil, JR; Popko, B; Weiner, M | 1 |
| Brugarolas, P; Clayton, BL; Collins, TL; Kunjamma, RB; Miller, RH; Miller, SD; Podojil, JR; Popko, B; Robinson, AP; Way, SW; Zaremba, A | 1 |
3 other study(ies) available for guanabenz and Multiple Sclerosis
| Article | Year |
|---|---|
Guanabenz modulates microglia and macrophages during demyelination.
Topics: Animals; Antihypertensive Agents; B7-2 Antigen; Central Nervous System; Demyelinating Diseases; Encephalomyelitis, Autoimmune, Experimental; Female; Guanabenz; Inflammation; Macrophage Activation; Macrophages; Mice; Mice, Inbred C57BL; Microglia; Multiple Sclerosis; Neurons; Nitric Oxide Synthase Type II; Oligodendroglia; Patient Safety; Phagocytosis; Remyelination | 2020 |
Sephin1, which prolongs the integrated stress response, is a promising therapeutic for multiple sclerosis.
Topics: Animals; Cells, Cultured; Encephalomyelitis, Autoimmune, Experimental; Female; Guanabenz; Humans; Immunity, Innate; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Oligodendroglia; Rats | 2019 |
Pharmaceutical integrated stress response enhancement protects oligodendrocytes and provides a potential multiple sclerosis therapeutic.
Topics: Animals; CD4-Positive T-Lymphocytes; Cell Differentiation; Cell Survival; Cells, Cultured; Central Nervous System; Cerebellum; Cytokines; Disease Models, Animal; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Female; Guanabenz; Inflammation; Interferon-gamma; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Myelin Sheath; Oligodendroglia; Rats; Rats, Sprague-Dawley; Stem Cells | 2015 |